Pentwater Capital Management Boosts Stake in Renalytix PLC (RENX) to 11.34%

Pentwater Capital Management Boosts Stake in Renalytix PLC (RENX) to 11.34% →

Pentwater Capital Management LP, a US-based investment firm headquartered in Naples, has announced a substantial increase in its combined stake in Renalytix PLC (RENX), the London-listed kidney disease diagnostics company. A TR-1 major hold…